Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 7,553

The DOI matches its Crossref record.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

·2005·The Lancet
DOI 10.1016/s0140-6736(05)66544-0
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(05)66544-0

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 18

  1. 1984, Review of mortality results in randomised trials in early breast cancer, Lancet, 2, 1205
  2. 1988, Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomised trials among 28 896 women, N Engl J Med, 319, 1681, 10.1056/NEJM198812293192601 · DOI · Paper page
  3. 1992, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women, Lancet, 339, 1
  4. 1992, Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women, Lancet, 339, 71, 10.1016/0140-6736(92)90997-H · DOI · Paper page
  5. 1995, Effects of radiotherapy and surgery in early breast cancer: an overview of the randomised trials, N Engl J Med, 333, 1444, 10.1056/NEJM199511303332202 · DOI · Paper page
  6. 1996, Ovarian ablation in early breast cancer: overview of the randomised trials, Lancet, 348, 1189, 10.1016/S0140-6736(96)05023-4 · DOI · Paper page
  7. 1998, Tamoxifen for early breast cancer: an overview of the randomised trials, Lancet, 351, 1451, 10.1016/S0140-6736(97)11423-4 · DOI · Paper page
  8. 1998, Polychemotherapy for early breast cancer: an overview of the randomised trials, Lancet, 352, 930, 10.1016/S0140-6736(98)03301-7 · DOI · Paper page
  9. 2000, Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials, Lancet, 355, 1757, 10.1016/S0140-6736(00)02263-7 · DOI · Paper page
  10. Peto, 1977, Design and analysis of randomised clinical trials requiring prolonged observation of each patient, part II: analysis and examples, Br J Cancer, 35, 1, 10.1038/bjc.1977.1 · DOI · Paper page
  11. Albain, 2004, Concurrent versus sequential chemohormonal therapy for postmenopausal receptor-positive breast cancer: mature outcomes and new biologic correlates in phase III intergroup trial 0100, Breast Cancer Res Treat, 88
  12. 1996, Randomised trial of 2 versus 5 years of adjuvant tamoxifen in postmenopausal early-stage breast cancer, J Natl Cancer Inst, 88, 1543, 10.1093/jnci/88.21.1543 · DOI · Paper page
  13. Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371 · DOI · Paper page
  14. Walsh, 2001, The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors, Ann New York Acad Sci, 949, 163, 10.1111/j.1749-6632.2001.tb04015.x · DOI
  15. Gray, 2000, Tamoxifen for early breast cancer: better late then never, Ann Oncol, 11, 505, 10.1023/A:1008323116265 · DOI
  16. Cocconi, 2003, Adjuvant chemotherapy in early breast cancer: optimal and suboptimal anthracycline-containing regimens, Breast Cancer Res Treat, 80, 313, 10.1023/A:1024955408785 · DOI
  17. Mariotto, 2002, Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States, 1979–1999, J Natl Cancer Inst, 94, 1626, 10.1093/jnci/94.21.1626 · DOI
  18. Peto, 2000, UK and USA breast cancer deaths down 25% in 2000 at ages 20–69 years, Lancet, 355, 1822, 10.1016/S0140-6736(00)02277-7 · DOI · Paper page

Cited by

See all 7,553

Metadata

Venue
The Lancet
Publisher
Elsevier BV
Published
2005-05
Volume
365
Issue
9472
Pages
1687-1717
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
DOI
10.1016/s0140-6736(05)66544-0
OpenAlex
W1961026612
Cited by
7,553
References
0
FWCI
136.96
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. https://app.cochat.ai/papers/10.1016/s0140-6736(05)66544-0
The paper
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. (2005). The Lancet. https://doi.org/10.1016/s0140-6736(05)66544-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.